Study of IgA in the cerebrospinal fluid of neurological patients with special reference to size, subclass and local production-Reference-Cited by-同舟云学术

Study of IgA in the cerebrospinal fluid of neurological patients with special reference to size, subclass and local production

Published:1984-01 Issue: Volume:7 Page:65-75
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Sindic C.J.M.,Delacroix D.L.,Vaerman J.P.,Laterre E.C.,Masson P.L.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference38 articles.

1. Particle counting immunoassay (PACIA), Part 1 (A general method for the determination of antibodies, antigens and haptens);Cambiaso;J. Immunol. Meth.,1977

2. In vitro regulation of IgA subclass synthesis, Part 1 (Discordance between plasma cell production and antibody secretion);Conley;J. Exp. Med.,1982

3. A solid-phase, direct competition, radioimmunoassay for quantitation of secretory IgA in human serum;Delacroix;J. Immunol. Meth.,1981

4. Influence of molecular size of IgA on its immunoassay by various techniques, Part 3 (Immunonephelometry);Delacroix;J. Immunol. Meth.,1982

5. Secretory component (SC) — Preferential binding to heavy (> 11S) IgA polymers and IgM in serum, in contrast to predominance of 11S and free SC forms in secretions;Delacroix;Clin. Exp. Immunol.,1982

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Cocaine IgA Rather Than IgG Mediates Vaccine Protection from Cocaine Use;Pharmaceutics;2022-11-03

2. Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers;Alzheimer's Research & Therapy;2022-08-26

3. High prevalence of intrathecal IgA synthesis in multiple sclerosis patients;Scientific Reports;2022-03-11

4. Know your enemy or find your friend?—Induction of IgA at mucosal surfaces;Immunological Reviews;2021-07-30

5. Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge;npj Vaccines;2021-05-13